Home > Balance Sheet > BETA DRUGS

BETA DRUGS
Total Current Liabilities

    Back to Balance Sheet
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹116 Cr₹113 Cr₹94 Cr₹70 Cr₹55 Cr

What is the latest Total Current Liabilities ratio of BETA DRUGS ?

The latest Total Current Liabilities ratio of BETA DRUGS is ₹116 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹116 Cr
Mar2025₹113 Cr
Mar2024₹94 Cr
Mar2023₹70 Cr
Mar2022₹55 Cr

How is Total Current Liabilities of BETA DRUGS Trending?

Years Total Current Liabilities % Change
Mar2026 ₹116 Cr
2.36
Mar2025 ₹113 Cr
20.11
Mar2024 ₹94 Cr
35.43
Mar2023 ₹70 Cr
27.09
Mar2022 ₹55 Cr -

Compare Total Current Liabilities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹1,996.2 Cr -9.1% -12.9% 2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-9.1%

-12.9%

2.8%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses